ABSTRACT
OBJECTIVE: Review the subsequent impact of recommendations made by the 2004 American Surgical Association Blue Ribbon Committee (BRC I) Report on Surgical Education. BACKGROUND: Current leaders of the American College of Surgeons and the American Surgical Association convened an expert panel to review the impact of the BRC I report and make recommendations for future improvements in surgical education. METHODS: BRC I members reviewed the 2004 recommendations in light of the current status of surgical education. RESULTS: Some of the recommendations of BRC I have gained traction and have been implemented. There is a well-organized national curriculum and numerous educational offerings. There has been greater emphasis on preparing faculty to teach and there are ample opportunities for professional advancement as an educator. The number of residents has grown, although not at a pace to meet the country's needs either by total number or geographic distribution. The number of women in the profession has increased. There is greater awareness and attention to resident (and faculty) well-being. The anticipated radical change in the educational scheme has not been adopted. Training in surgical research still depends on the resources and interests of individual programs. Financing student and graduate medical education remains a challenge. CONCLUSIONS: The medical landscape has changed considerably since BRC I published its findings in 2005. A contemporary assessment of surgical education and training is needed to meet the future needs of the profession and our patients.
ABSTRACT
BACKGROUND: Type II hiatal hernias (HH) are characterized by a portion of the gastric fundus located above the esophageal hiatus adjacent to the esophagus while the gastroesophageal junction (GEJ) remains fixed below the esophageal hiatus. This type of HH has been called the "true" paraesophageal hernia (PEH) because the fundus appears to the side of the esophagus. In our experience, Type II HHs are occasionally identified on radiographic testing, however they are rarely, if ever, confirmed intraoperatively. This led to our question: Does Type II HH exist? METHODS: We searched for evidence of type II HH in three locations: 1. Retrospective review of all first-time PEH repairs (excluding Type I HHs and re-operative cases) performed at the University of Washington Medical Center from 1994 to 2021; 2. Operative videos available on YouTube and WebSurg websites; and 3. Abstracts from the SAGES annual meetings from 2005 to 2021. RESULTS: We found no evidence of Type II HH in any of our three searches. We performed 846 PEH repairs: 760 Type III, 75 Type IV, and 11 parahiatal. Upon website video review, we found only one possible type II hernia, though it too was likely a para-hiatal hernia. No video or case presentations of a type II HH were identified within SAGES annual meeting abstracts. CONCLUSION: Type II HHs do not exist as they are currently defined. Although uncommon, parahiatal hernia can easily be misinterpreted as Type II HH. We should consider changing the hiatal hernia classification system to prevent ongoing clinical confusion.
Subject(s)
Hernia, Hiatal , Laparoscopy , Humans , Hernia, Hiatal/surgery , Esophagus/surgery , Diaphragm , Esophagogastric JunctionABSTRACT
We sought to assess whether laparoscopic anti-reflux surgery (LARS) is associated with decreased rates of disease progression in patients with idiopathic pulmonary fibrosis (IPF).The study was a retrospective single-centre study of IPF patients with worsening symptoms and pulmonary function despite antacid treatment for abnormal acid gastro-oesophageal reflux. The period of exposure to LARS was September 1998 to December 2012. The primary end-point was a longitudinal change in forced vital capacity (FVC) % predicted in the pre- versus post-surgery periods.27 patients with progressive IPF underwent LARS. At time of surgery, the mean age was 65â years and mean FVC was 71.7% pred. Using a regression model, the estimated benefit of surgery in FVC % pred over 1â year was 5.7% (95% CI -0.9-12.2%, p=0.088) with estimated benefit in FVC of 0.22â L (95% CI -0.06-0.49â L, p=0.12). Mean DeMeester scores decreased from 42 to 4 (p<0.01). There were no deaths in the 90â days following surgery and 81.5% of participants were alive 2â years after surgery.Patients with IPF tolerated the LARS well. There were no statistically significant differences in rates of FVC decline pre- and post-LARS over 1â year; a possible trend toward stabilisation in observed FVC warrants prospective studies. The ongoing prospective randomised controlled trial will hopefully provide further insights regarding the safety and potential efficacy of LARS in IPF.
Subject(s)
Gastroesophageal Reflux/surgery , Idiopathic Pulmonary Fibrosis/surgery , Laparoscopy , Adult , Aged , Disease Progression , Female , Gastroesophageal Reflux/complications , Humans , Hydrogen-Ion Concentration , Idiopathic Pulmonary Fibrosis/diagnosis , Male , Middle Aged , Perioperative Period , Regression Analysis , Respiratory Function Tests , Retrospective Studies , Smoking , Tomography, X-Ray Computed , Treatment Outcome , Vital CapacityABSTRACT
INTRODUCTION: Laparoscopic hiatal hernia repair has a better chance of success if the hiatus is closed without tension. This study attempts to answer the following questions: (1) What is the rate of hiatal hernia recurrence in patients who undergo hiatal closure with diaphragmatic relaxing incisions? (2) Can biologic mesh be safely substituted for synthetic mesh as coverage of the relaxing incisions? METHODS: We identified all patients who underwent laparoscopic hiatal hernia repair at our institution between 2007 and 2013 and reviewed their clinical records. Radiologic recurrence was identified by an experienced radiologist and defined as the presence of any abdominal contents located above the diaphragm on esophagram. Clinical recurrence was defined as little or no improvement in symptoms, the development of a new symptom, or the need for medical, endoscopic, or surgical treatment of postoperative symptoms. RESULTS: A minimum of 6 months of radiologic and clinical follow-up was available for 146 (40 %) patients, including 16 with relaxing incisions. There were 66 (45 %) recurrent hernias detected on esophagram. There was no difference in the rate of recurrent hiatal hernia among the three groups: Primary closure of the hiatus (21/36 [58 %]), primary closure with biologic mesh reinforcement (36/94 [38 %]), and relaxing incision with biologic mesh reinforcement (9/16 [56 %]; p = 0.428). Two reoperations were performed on patients who underwent left relaxing incisions and developed symptomatic diaphragmatic hernias through the left relaxing incisions. There were no complications associated with use of biologic mesh at the hiatus. CONCLUSIONS: Rate of recurrent hiatal hernia is similar between patients who undergo diaphragmatic relaxing incisions and patients who undergo primary hiatal closure. Relaxing incisions can be safely performed on either crus; however, biologic mesh should not be used to patch a left-sided relaxing incision due to the risk of developing a diaphragmatic hernia.
Subject(s)
Hernia, Hiatal/surgery , Herniorrhaphy/methods , Laparoscopy , Surgical Mesh , Biocompatible Materials , Female , Hernia, Hiatal/diagnostic imaging , Hernia, Hiatal/pathology , Herniorrhaphy/instrumentation , Humans , Laparoscopy/methods , Male , Middle Aged , Recurrence , Retrospective Studies , Treatment OutcomeSubject(s)
Achievement , Clinical Competence , General Surgery/education , Surgeons/education , Surgical Procedures, Operative/methods , General Surgery/methods , Humans , Interdisciplinary Communication , Patient Care Team/organization & administration , Practice Patterns, Physicians' , United StatesSubject(s)
Career Mobility , General Surgery , Hospital Administration , Leadership , Congresses as Topic , Humans , Societies, Medical , United StatesABSTRACT
OBJECTIVES: There is considerable discussion regarding "success" rates for laparoscopic antireflux surgery (LARS). We hypothesized that, in part, this was a reflection of the outcome variables used. We, therefore, defined 8 specific variables (within 3 categories) and assessed outcomes for each in a large cohort of patients. METHODS: Four hundred patients (208 women; median age 52 years old) who underwent LARS at the University of Washington from 1993 to 2008 were given a comprehensive questionnaire to assess various aspects of their outcomes from LARS. In addition, we analyzed all functional studies and all endoscopies performed in these patients in our institution, whether the patients had symptoms or not, and compared the findings to all available preoperative values. RESULTS: The median follow-up was 92 (6-175) months. CONCLUSIONS: The success or failure of LARS cannot be defined in a single domain. A comprehensive analysis of outcomes requires categorization that includes symptom response, side-effects, patient's perception and objective measurement of acid exposure, mucosal integrity, and the need for additional medical or surgical treatment. Only then can patients and physicians better understand the role of LARS and make informed decisions.
Subject(s)
Gastroesophageal Reflux/surgery , Barrett Esophagus/complications , Combined Modality Therapy , Disease Progression , Esophageal Neoplasms/epidemiology , Female , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/drug therapy , Gastroesophageal Reflux/physiopathology , Humans , Laparoscopy , Male , Middle Aged , Monitoring, Ambulatory , Proton Pump Inhibitors/therapeutic use , Reoperation , Treatment OutcomeABSTRACT
BACKGROUND: Biologic mesh is widely used for repair of large, complicated hiatal hernias. Recently, there have been reports of complications after its implantation. We studied the course of a large group of patients who had undergone hiatal hernia repair with use of biologic mesh to determine the rate of immediate and late complications related to its use. METHODS: All patients who had biologic mesh placed at the hiatus and who had been followed for at least 1 year were included. Perioperative data were reviewed, and a questionnaire was administered, designed to identify symptoms of gastroesophageal reflux, other symptoms such as dysphagia, and all other operative or endoscopic interventions that occurred after mesh implantation. In addition, postoperative radiologic and endoscopic studies were reviewed to assess signs of complications related to use of mesh. RESULTS: There were 126 patients eligible for the study. We were able to contact 73 of these patients, at median follow-up of 45 months. No mesh-related complications were found. The frequency and severity of heartburn, regurgitation, and dysphagia improved significantly compared with preoperative values, and 89% of the patients reported good to excellent results in terms of overall satisfaction. Six patients recorded worsening of dysphagia postoperatively, but after careful work-up and review of each individual case, no case seemed to be directly related to the mesh. No erosions, strictures, or other complications directly related to use of mesh were found. One patient required reoperation due to hiatal hernia recurrence with gastroesophageal reflux disease (GERD) symptoms. CONCLUSIONS: Use of biologic mesh for laparoscopic repair of large, complicated hiatal hernias appears safe. There were no major complications related to the mesh, and overall satisfaction with the operation was very good.
Subject(s)
Hernia, Hiatal/surgery , Herniorrhaphy/methods , Laparoscopy/adverse effects , Surgical Mesh/adverse effects , Aged , Deglutition Disorders/etiology , Female , Gastroesophageal Reflux/etiology , Humans , Length of Stay , Male , Middle Aged , Postoperative Complications/etiology , Risk FactorsABSTRACT
BACKGROUND: Most epiphrenic diverticula traditionally have been approached through a left thoracotomy. Because laparoscopy provides excellent exposure to the distal esophagus and decreases the morbidity of thoracoscopy or thoracotomy, we have used it preferentially since 1997 and routinely since 2001. This study describes our experience with this approach. METHODS: From 1997 to 2008, 23 patients underwent surgery for epiphrenic diverticula at the University of Washington so that all patients are ≥2 years out. Our initial approach was via laparoscopy in 19 patients, VATS in 2, and open thoracotomy in 2. Details of the operation and postoperative course were recorded in our database. The patients were contacted by one of the investigators regarding current symptoms. RESULTS: The median age was 57 (range 23-83) years. The medium follow-up was 45 months. Eighteen patients had esophageal manometry at our institution; 12 of them were abnormal (66.67%). The median diameter of diverticula was 4 (range 2-10) cm. From the 19 patients approached by laparoscopy, there was one conversion to open thoracotomy in a patient with an associated leiomyoma. Both patients approached by VATS were converted to thoracotomy. Patients initially approached by laparoscopy had a median length of stay of 3 days. There was one contained esophageal leak. One patient died within 30 days from complications of the operation. Ninety-two percent of patients reported improvement of their dysphagia and 77% improvement of regurgitation. None of the patients developed recurrent diverticula. Eighty-five percent of the patients rated the results of the operation as good or excellent. CONCLUSIONS: Most epiphrenic diverticula can be treated successfully by using a laparoscopic approach. Morbidity and conversion rates are low and symptom control is excellent.
Subject(s)
Diverticulum, Esophageal/surgery , Esophagoscopy/methods , Postoperative Complications/etiology , Adult , Aged , Aged, 80 and over , Female , Humans , Length of Stay , Male , Middle Aged , Preoperative Care/methods , Surveys and Questionnaires , Treatment Outcome , Young AdultABSTRACT
Professionalism is an inherent attribute to the practice of surgery. Historically, the importance of this quality arose later than the earliest three fundamental principles of medical knowledge, diagnostic ability, and technical skill. In the modern era, society has clearly come to require that its surgeons embrace professionalism as a fundamental principle. It now stands among the six core competencies that all United States training programs teach and measure. We define professionalism as the pursuit of excellence, the display of humanism, an altruistic commitment, and accountability to all interactions with society. Surgeons teach professionalism to their trainees every day, sometimes by formal curricula but more often by the unspoken and unsuspected modeling of behavior. These methods can be structured into a teaching program. To that program, active practice and engagement in continuous professionalism improvement ought to be added. In this way, a true method of professionalism training can be made that allows for formal assessment.
Subject(s)
Competency-Based Education/methods , Education, Medical, Graduate/methods , Educational Measurement/methods , General Surgery/education , Interpersonal Relations , Aptitude , Humans , United StatesSubject(s)
General Surgery/trends , Surgeons/trends , Forecasting , Societies, Medical , United StatesSubject(s)
Ethics, Medical , General Surgery/ethics , Physician-Patient Relations/ethics , Surgeons/ethics , HumansABSTRACT
This paper reviews the rationale for the development of an accreditation program for Educational Institutes by the American College of Surgeons. It discusses the reasons why such accreditation program is beneficial to the institutes themselves as well as to the organizations that sponsor the institute. It analyzes the evolution of the accreditation program since its inception, and it provides advice as to how to start the accreditation process.
Subject(s)
Academies and Institutes/standards , Accreditation , General Surgery/education , General Surgery/standards , Clinical Competence , Humans , United StatesABSTRACT
Paraesophageal hernia repair has been associated with a recurrence rate of up to 42%. Thus, in the last decade, there has been increasing interest in the use of mesh reinforcement of the hiatal repair. Polytetrafluoroethylene (PTFE) is one of the materials that have been used for this purpose, as it is thought to induce minimal tissue reaction. We report two cases in which complications specific to the use of PTFE mesh in this location developed over time. In the first patient, a gastrectomy was required to remove a large PTFE mesh which had eroded into the esophagogastric junction and gastric cardia. The second patient experienced severe dysphagia resulting from a stricture caused by the implant, requiring removal of the mesh. Although such complications have only rarely been reported, the severity and consequences of these incidents, as reported in the literature and in light of our observations, suggest that an alternative to PTFE should be considered for crural reinforcement during paraesophageal hernia repair.
Subject(s)
Diaphragm/surgery , Hernia, Hiatal/surgery , Polytetrafluoroethylene , Surgical Mesh/adverse effects , Aged , Deglutition Disorders/etiology , Esophageal Stenosis/etiology , Female , Foreign-Body Migration/diagnosis , Foreign-Body Migration/surgery , Humans , Male , Middle Aged , Recurrence , Reoperation , StomachABSTRACT
BACKGROUND: Abnormal acid gastro-oesophageal reflux (GER) is hypothesised to play a role in progression of idiopathic pulmonary fibrosis (IPF). We aimed to determine whether treatment of abnormal acid GER with laparoscopic anti-reflux surgery reduces the rate of disease progression. METHODS: The WRAP-IPF trial was a randomised controlled trial of laparoscopic anti-reflux surgery in patients with IPF and abnormal acid GER recruited from six academic centres in the USA. We enrolled patients with IPF, abnormal acid GER (DeMeester score of ≥14·7; measured by 24-h pH monitoring) and preserved forced vital capacity (FVC). We excluded patients with a FVC below 50% predicted, a FEV1/FVC ratio of less than 0·65, a history of acute respiratory illness in the past 12 weeks, a body-mass index greater than 35, and known severe pulmonary hypertension. Concomitant therapy with nintedanib and pirfenidone was allowed. The primary endpoint was change in FVC from randomisation to week 48, in the intention-to-treat population with mixed-effects models for repeated measures. This trial is registered with ClinicalTrials.gov, number NCT01982968. FINDINGS: Between June 1, 2014, and Sept 30, 2016, we screened 72 patients and randomly assigned 58 patients to receive surgery (n=29) or no surgery (n=29). 27 patients in the surgery group and 20 patients in the no surgery group had an FVC measurement at 48 weeks (p=0·041). Intention-to-treat analysis adjusted for baseline anti-fibrotic use demonstrated the adjusted rate of change in FVC over 48 weeks was -0·05 L (95% CI -0·15 to 0·05) in the surgery group and -0·13 L (-0·23 to -0·02) in the non-surgery group (p=0·28). Acute exacerbation, respiratory-related hospitalisation, and death was less common in the surgery group without statistical significance. Dysphagia (eight [29%] of 28) and abdominal distention (four [14%] of 28) were the most common adverse events after surgery. There was one death in the surgery group and four deaths in the non-surgery group. INTERPRETATION: Laparoscopic anti-reflux surgery in patients with IPF and abnormal acid GER is safe and well tolerated. A larger, well powered, randomised controlled study of anti-reflux surgery is needed in this population. FUNDING: US National Institutes of Health National Heart, Lung and Blood Institute.
Subject(s)
Gastroesophageal Reflux/surgery , Idiopathic Pulmonary Fibrosis/surgery , Laparoscopy , Aged , Disease Progression , Female , Gastroesophageal Reflux/complications , Humans , Idiopathic Pulmonary Fibrosis/complications , Idiopathic Pulmonary Fibrosis/mortality , Intention to Treat Analysis , Male , Middle Aged , Treatment Outcome , Vital CapacityABSTRACT
The University of Washington (UW) School of Medicine is in the midst of an emerging ecology of professionalism. This initiative builds on prior work focusing on professionalism at the student level and moves toward the complete integration of a culture of professionalism within the UW medical community of including staff, faculty, residents, and students. The platform for initiating professionalism as institutional culture is the Committee on Continuous Professionalism Improvement, established in November 2006. This article reviews three approaches to organizational development used within and outside medicine and highlights features that are useful for enhancing an institutional culture of professionalism: organizational culture, safety culture, and appreciative inquiry. UW Medicine has defined professional development as a continuous process, built on concrete expectations, using mechanisms to facilitate learning from missteps and highlighting strengths. To this end, the school of medicine is working toward improvements in feedback, evaluation, and reward structures at all levels (student, resident, faculty, and staff) as well as creating opportunities for community dialogues on professionalism issues within the institution. Throughout all the Continuous Professionalism Improvement activities, a two-pronged approach to cultivating a culture of professionalism is taken: celebration of excellence and attention to accountability.